Launch of Bovalto Respi 4
MCI Santé Animale participated on April 05 and 06, 2019 in the 3rd edition of the Congress of the Veterinary Technical Group held in Marrakech. This event had significant participation of veterinarians from different regions of the Kingdom and made it possible to create a framework for exchange between the professionals present.
During this congress, MCI Santé Animale and Boehringer Ingelheim organized a Technical Symposium dealing with the issue of Enzootic Infectious Broncho-Pneumonia (BPIE) in cattle. during this symposium, Dr. D.Champenois of the Cristal France network led a presentation on the management of BPIE in fattening farms in France. FOR THEIR PART, Dr. A. Ouachem and Dr. T.Rawi drew up a picture of these conditions in Morocco and presented a new solution against BPIE: BOVALTO Respi 4, inactivated vaccine against Pi3, BRSV, BVD, and Mannheimia Haemolytica.
Other news
L’innovation continue au service de l’élevage : Bovalto Respi Intranasal, une première au Maroc
MCI Santé Animale, en partenariat avec Boehringer Ingelheim, annonce l’introduction au Maroc de Bovalto Respi Intranasal, premier vaccin intranasal destiné aux jeunes veaux.
Read more +
Rift Valley Fever Re-emergence in West Africa
Rift Valley Fever (RVF) is a mosquito-borne viral zoonosis that affects primarily livestock such as cattle, goats, sheep, camels, and buffalo, causing high mortality and abortion rates that lead to significant economic losses.
Read more +
Participation of MCI Santé Animale at WVPAC 2023
MCI Santé Animale participated from September 4 to 8, 2023 in the 22nd World Congress organized by the World Association of Avian Veterinarians which was held in Verona, Italy.
Read more +
VET PRACTICE MANAGEMENT
MCI Santé Animale in collaboration with its partner Boehringer Ingelheim have organized a Roadshow, the topic was: "VET PRACTICE MANAGEMENT", between May 09 and 12 2023, in 3 cities of Morocco: Fez, Mohammedia, and Marrakech.
Read more +